Elsevier

Neuroscience Letters

Volume 350, Issue 1, 16 October 2003, Pages 25-28
Neuroscience Letters

Apolipoprotein E −491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population

https://doi.org/10.1016/S0304-3940(03)00815-2Get rights and content

Abstract

Polymorphisms at positions −491, −427 and −219 in the promoter region of the Apolipoprotein E APOE gene have been variously reported to confer an increased risk of developing Alzheimer's disease (AD) independent of the effect of ε2, 3 or 4 alleles in exon 4. In order to assess APOE promoter polymorphisms as independent risk factors in AD we have compared results in 183 definite or probable AD cases with 133 controls. We assayed markers at sites −491, −427, −219, and +113 in APOE gene and a polymorphic Hha1 site in the nearby APOC1 gene. We found that APOE promoter polymorphisms and APOC1 insertion alleles were significantly associated with AD. However, after stratification for ε4 allele, only the A allele at −491 in APOE remained significantly associated with AD. The effects of the other markers depended almost entirely upon linkage disequilibrium with ε4 allele, and only trends remained when cases and controls were stratified for the presence or absence of ε4 allele. This occurred irrespective of whether markers were examined separately or together as haplotypes. So in the Chinese population only APOE −491 promoter alleles confer significant risk of AD independent of ε4 status.

Section snippets

Acknowledgements

The work was supported by grants from the national 973 Project, the National Natural Science Foundation of China and the Royal Society of the UK, Qiu Shi Science & Technologies Foundation, and Shanghai Municipal Commission for Science and Technology.

References (27)

View full text